[1] |
HAN Junya, WU Weiwei, HE Xiaojun, ZHU Wenwen, FANG Xianfeng.
Related factors analysis and prediction model establishment of malignant tumor in patients with bullous pemphigoid
[J]. China Journal of Leprosy and Skin Diseases, 2024, 40(3): 157-162.
|
[2] |
CHANG Jiayu, QI Miao, WANG Yimin, LI Yongxi, SHI Tongxin.
Bullous pemphigoid occurred in a patient with severe plaque psoriasis treated with secukinumab: a case report
[J]. China Journal of Leprosy and Skin Diseases, 2024, 40(3): 199-201.
|
[3] |
ZENG Lingling, YAN Fang, CHENG Jian.
A case of atypical monkeypox
[J]. China Journal of Leprosy and Skin Diseases, 2024, 40(1): 1-2.
|
[4] |
ZHOU Yuxi, LI Jishu, WANG Jinqiu, LI Xiaohong, FENG Chenchen, ZHOU Xingli, LI Wei.
Efficacy and safety of dupilumab in the treatment of bullous pemphigoid for 16 weeks: a retrospective study
[J]. China Journal of Leprosy and Skin Diseases, 2024, 40(1): 21-25.
|
[5] |
JIA Fengming, FANG Meng, LIU Yongxia, LIU Hong.
Dupilumab alone successfully treated an elderly patient with bullous pemphigoid
[J]. China Journal of Leprosy and Skin Diseases, 2023, 39(9): 661-663.
|
[6] |
ZHU Yao, CHEN Weiquan, WU Wei, CAI Yanxia, XIE Yingxia, LIU Yaqin.
Congenital connective tissue nevus of the scalp with alopecia: a case report
[J]. China Journal of Leprosy and Skin Diseases, 2023, 39(9): 673-674.
|
[7] |
ZHANG Kun, CHEN Lixiu.
Bullous pemphigoid with positive pemphigus antibody in erythroderma: a case report
[J]. China Journal of Leprosy and Skin Diseases, 2023, 39(8): 606-608.
|
[8] |
WANG Zexin, YAN Aixia, SONG Qing.
Neonate with nonbullous congenital ichthyosiform erythroderma: a case report
[J]. China Journal of Leprosy and Skin Diseases, 2023, 39(7): 530-532.
|
[9] |
ZHAO Dandan, ZHEN Li.
Analysis of the prognostic factors of bullous pemphigoid based on random forest model
[J]. China Journal of Leprosy and Skin Diseases, 2023, 39(5): 338-343.
|
[10] |
LIU Wenhong, YU Shaohua, KANG Ting, YUAN Yuan, ZHANG Renjuan, DU Hua, HE Chunfeng.
Bullous pemphigoid induced by multiple tumors was treated with PD-1 inhibitor: a case report
[J]. China Journal of Leprosy and Skin Diseases, 2023, 39(5): 364-366.
|
[11] |
DENG Wei, SU Wei, ZHANG Gaolei, LIU Xiaoyan.
Congenital myxoid dermatofibrosarcoma protuberans: a case report and literature review
[J]. China Journal of Leprosy and Skin Diseases, 2023, 39(3): 167-172.
|
[12] |
CHEN Jianyou, SU Wei, LIU Xiaoyan, ZHANG Gaolei.
Correlation of BRAF V600E gene mutation with proliferative activity and histopathological characteristics of congenital melanocytic nevi in children
[J]. China Journal of Leprosy and Skin Diseases, 2023, 39(2): 77-81.
|
[13] |
TIAN Caidie, ZHENG Zheng, YANG Dingquan, LIU Qingwu, DUAN Xinxin, KOU Nan, LI Nan.
Aplasia cutis congenital of the scalp: a case report
[J]. China Journal of Leprosy and Skin Diseases, 2023, 39(2): 112-114.
|
[14] |
SHAO Lifang, TIAN Rong, KONG Weixin, JING Qi, YUAN Xiaoying.
Dupilumab combined with glucocorticoid in the treatment of 4 cases with severe bullous pemphigoid
[J]. China Journal of Leprosy and Skin Diseases, 2023, 39(12): 890-893.
|
[15] |
SUN Lin, DONG Zhengbang, WANG Fei.
Highly selective JAK1 inhibitor for the treatment of refractory bullous pemphigoid: a case report
[J]. China Journal of Leprosy and Skin Diseases, 2023, 39(12): 906-908.
|